Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1998 1
2001 1
2004 1
2006 1
2007 1
2008 1
2010 1
2011 2
2012 2
2013 4
2014 7
2015 6
2016 9
2017 8
2018 14
2019 14
2020 18
2021 19
2022 19
2023 20
2024 19
2025 31
2026 15

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

195 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean kinase a[au] (61 results)?
Allogeneic haematopoietic cell transplantation in peripheral T-cell lymphoma: recommendations from the EBMT Practice Harmonisation and Guidelines Committee.
Damaj G, Bazarbachi A, Berning P, Cottereau AS, Fox CP, Kyriakou C, Cwynarski K, Zinzani PL, Tournilhac O, Jurczak W, Karsten IE, Wang F, Marcais A, Tanase A, Nguyen-Quoc S, Serroukh Y, Aljurf M, Beauvais D, Wulf G, Sureda A, Corradini P, Hermine O, Hamadani M, Onida F, Ruggeri AL, Sanchez-Ortega I, Yakoub-Agha I, Dreger P, Schmitz N. Damaj G, et al. Among authors: tanase a. Lancet Haematol. 2025 Jul;12(7):e542-e554. doi: 10.1016/S2352-3026(25)00073-0. Lancet Haematol. 2025. PMID: 40610175 Review.
Once-daily, single-inhaler mometasone-indacaterol-glycopyrronium versus mometasone-indacaterol or twice-daily fluticasone-salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study.
Kerstjens HAM, Maspero J, Chapman KR, van Zyl-Smit RN, Hosoe M, Tanase AM, Lavecchia C, Pethe A, Shu X, D'Andrea P; IRIDIUM trial investigators. Kerstjens HAM, et al. Among authors: tanase am. Lancet Respir Med. 2020 Oct;8(10):1000-1012. doi: 10.1016/S2213-2600(20)30190-9. Epub 2020 Jul 9. Lancet Respir Med. 2020. PMID: 32653074 Clinical Trial.
Adoptive cellular therapies in multiple myeloma.
Kegyes D, Borlea B, Damian M, Tigu AB, Nistor M, Cenariu D, Munteanu R, Gulei D, Dascalescu A, Antohe I, Tanase A, Terpos E, Einsele H, Tomuleasa C. Kegyes D, et al. Among authors: tanase a. Best Pract Res Clin Haematol. 2025 Sep;38(3):101638. doi: 10.1016/j.beha.2025.101638. Epub 2025 May 27. Best Pract Res Clin Haematol. 2025. PMID: 40915705 Free article. Review.
CARing about autoimmune disorders. Use of chimeric antigen receptor engineered T-cells in autoimmune diseases.
Tigu AB, Nistor M, Gulei D, Constantinescu CS, Kegyes D, Cenariu D, Muresan X, Munteanu R, Feder R, Jitaru C, Bancos A, Santa M, Tomai R, Damian M, Ivancuta A, Rus I, Bojan A, Zdrenghea M, Buzoianu AD, Tanase A, Einsele H, Kobold S, Tomuleasa C. Tigu AB, et al. Among authors: tanase a. Blood Rev. 2026 Jan;75:101354. doi: 10.1016/j.blre.2025.101354. Epub 2025 Nov 26. Blood Rev. 2026. PMID: 41318274 Free article. Review.
Adoptive cellular therapies in non-Hodgkin lymphomas.
Kegyes D, Borlea B, Damian M, Tigu AB, Nistor M, Cenariu D, Munteanu R, Gulei D, Dascalescu A, Antohe I, Tanase A, Colita A, Shokun N, Skrypets T, Einsele H, Federico M, Tomuleasa C. Kegyes D, et al. Among authors: tanase a. Best Pract Res Clin Haematol. 2025 Sep;38(3):101637. doi: 10.1016/j.beha.2025.101637. Epub 2025 May 22. Best Pract Res Clin Haematol. 2025. PMID: 40915701 Free article. Review.
Allogeneic hematopoietic cell transplant in cutaneous T-cell lymphomas: recommendations from the EBMT PH&G Committee.
Damaj G, de Masson A, Dreger P, Bazarbachi A, Berning P, Duarte RF, Fox CP, Guenova E, Hermine O, Kyriakou C, Tanase A, Tournilhac O, Jurczak W, Karsten IE, Quoc SN, Serroukh Y, Stella F, Wulf G, Sureda A, Papadavid E, Ortiz-Romero PL, Ruggeri A, Sánchez-Ortega I, Scarisbrick JJ, Yakoub-Agha I, Onida F, Schmitz N. Damaj G, et al. Among authors: tanase a. Bone Marrow Transplant. 2025 Dec;60(12):1565-1573. doi: 10.1038/s41409-025-02696-x. Epub 2025 Oct 1. Bone Marrow Transplant. 2025. PMID: 41034407 Free PMC article. Review.
Progress in Hematopoietic Stem Cell Transplantation and Cellular Therapies.
Cenariu D, Bumbea H, Colita A, Constantinescu C, Desmirean M, Iluta S, Lysák D, Mussetti A, Tichil I, Tanase A, Tomuleasa C. Cenariu D, et al. Among authors: tanase a. J Clin Med. 2022 Dec 10;11(24):7354. doi: 10.3390/jcm11247354. J Clin Med. 2022. PMID: 36555970 Free PMC article.
Targeting degradation of IKZF1 and IKZF3 through modulation of the E3 ligase substrates in the context of cellular therapies for multiple myeloma.
Kegyes D, Bancos A, Tigu AB, Rus I, Dima D, Cenariu D, Nistor M, Munteanu R, Gulei D, Tanase A, Colita A, Buzoianu A, Iuga C, Zdrenghea M, Terpos E, Ciurea SO, Ciechanover A, Einsele H, Tomuleasa C. Kegyes D, et al. Among authors: tanase a. Biomark Res. 2025 Aug 15;13(1):105. doi: 10.1186/s40364-025-00825-8. Biomark Res. 2025. PMID: 40817326 Free PMC article. Review.
195 results